A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
about
N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancersG-protein inwardly rectifying potassium channel 1 (GIRK 1) gene expression correlates with tumor progression in non-small cell lung cancerFactors affecting 30-month survival in lung cancer patientsKi-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studiesPrognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancerGenetics and pulmonary medicine. 7. Somatic mutations in the development of lung cancer.Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancerProtein signature for non-small cell lung cancer prognosis.Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysisLong-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literatureEPMA position paper in cancer: current overview and future perspectives.Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosisCD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancerHigh predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC)Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysisPrediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissueAberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosisPrognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633.Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.Serum p53 antibodies: predictors of survival in small-cell lung cancer?Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image featuresPre-existing Pulmonary Diseases and Survival in Patients With Stage-dependent Lung Adenocarcinoma: A STROBE-compliant Article.MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patientsCross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer.Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer.New prognostic factors in resectable non-small cell lung cancer.Detection of HER2 polymorphism and expression using circulating DNA and RNA as a tool in lung adenocarcinoma patients: a case control studyPrediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images.Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.p53 and angiogenesis in non-small-cell lung cancer: Reply to the letter from Giatromanolaki and Koukourakis.Association between smoking and tumor progression in Japanese women with adenocarcinoma of the lung.
P2860
Q24648283-702D7C27-CC72-4002-BDB8-82911BF664A6Q24802461-BB771329-0C25-471E-95F1-EE42148A5008Q28710394-F1678288-7739-4715-8638-7A2EBC606C05Q30657753-45C10F2E-A4BA-4605-A196-48D2AFCB3601Q33252508-FEB65FD4-555B-4F19-AA26-5D80D767ED92Q33588251-91531F80-EA5B-4B60-88C4-848D42CF9322Q33645624-5522ED83-59AC-4556-BB4B-4057803C2A16Q33785608-5C76BF6D-84DB-4E29-95D2-5CDEA1E77453Q33811206-CD88DA23-FB85-4D6C-88BE-CE3E7B786392Q34110425-9358B501-BA01-47CA-B513-6C63079C42A5Q34130681-B61878AF-7160-40B9-9939-98DCFF4F1A75Q35216052-6D100728-7F33-4EFA-AB7D-A4B4E9299DF7Q35532215-BF6D00E1-5F1B-4349-8C4A-BD28C07FFD81Q35587101-0E5B25DC-3B78-4924-B8BE-EBF3C35A0839Q35587969-5E0D4C97-1F24-4036-BBD4-F391C419AC67Q35769805-15C4F99E-4A5A-40F2-8604-A0008158FF0BQ35951523-4C578EE4-E8FD-44CB-9F07-30BF8D0C7EA7Q36116240-77520D7D-8E2D-4946-ABDB-D553FE9E8820Q36324689-3FF22C51-F231-47BD-9CE8-374D8D770A8EQ36421289-7C837237-216D-45D7-846B-8C8BC741502CQ36552786-6122DF1D-5F0E-49C6-9031-11939F50BD4EQ36618912-3951199A-C10C-4D4D-A344-21D1ABA0DC50Q36621503-5C496E38-2085-4D9D-B504-349B4F0CF423Q37188409-F4D3F6A4-523C-4306-A75B-CF0EA6CBAB19Q37207053-CEC94A75-1EC3-4411-A4D1-9726582784DFQ37227208-EE0B3DF7-BB7A-42D4-B829-FEC3EEFC805AQ37244584-64443775-BF13-48B1-AD6F-079B48F01212Q37323814-EC44F14D-7BA1-4C37-ABC7-CC27381CCAC4Q39192389-FE3FD011-43F1-4B95-99F4-F1DA864000F5Q41023437-83B351E1-1CC6-4D4B-AEDF-E5D8018519A9Q42106918-5E0088A2-E571-4FCB-A636-91C6D0968DC0Q42659721-8C2E79D7-47DE-4B5E-BBE5-043AFB294E97Q45943784-60BEE87B-D679-4467-9161-32D4EAB115E1Q46698755-08BAD142-A7F4-4FF6-BDCC-821E4919A1E9Q54936006-6A350F9A-E030-4462-A490-ECD4D22D4AB2
P2860
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
A prognostic model of recurren ...... y, and oncoprotein expression.
@en
type
label
A prognostic model of recurren ...... y, and oncoprotein expression.
@en
prefLabel
A prognostic model of recurren ...... y, and oncoprotein expression.
@en
P2093
P1433
P1476
A prognostic model of recurren ...... gy, and oncoprotein expression
@en
P2093
Harpole DH Jr
Herndon JE 2nd
Iglehart JD
P407
P577
1995-01-01T00:00:00Z